National
News
Features
Profiles/Interviews
Local Sports
Global
Football
Middle East
Basketball
Africa
Europe
Americas
Asia
Baseball
Cricket
Australasia
Racing
Rugby
Olympics
Yalla Jordan
The Royal wedding
Where to Go
Around Jordan
Cartoon
Business
Economy
Trade & Industry
Entrepreneurship
Opinion & Analysis
Analysis
Opinion
Lifestyle
Good Food
Health
Fashion
Culture & Arts
Travel
Entertainment
Education
Music
Technology
Gaming
Drive
Reviews
Books
Trending
Odd & Bizarre
Property
Weather
Home
National
News
Features
Profiles/Interviews
Local Sports
Global
REGION & WORLD
Middle East
Africa
Europe
Americas
Asia
Australasia
SPORTS
Football
Basketball
Baseball
Cricket
Racing
Rugby
Olympics
Yalla Jordan
The Royal wedding
Where to Go
Around Jordan
Cartoon
Business
Economy
Trade & Industry
Entrepreneurship
Opinion & Analysis
Analysis
Opinion
Lifestyle
Good Food
Health
Fashion
Culture & Arts
Travel
Entertainment
Education
Music
Technology
Gaming
Drive
Reviews
Books
Trending
Odd & Bizarre
Property
Weather
Breaking News:
Jordan Affirms Support for Bahrain’s Measures to Protect Sovereignty and Security
Trump Announces Three-Day Truce Between Russia and Ukraine
WHO: All Hanta Virus Cases Linked to Cruise Ship
Al-Sawa'ir: Petra’s Tourism Faces Difficult Conditions Due to Sharp Decline in Foreign Tourists
Amman Chamber of Industry Exports Grow by 9.2% in the First Four Months of 2026
Saudi Arabia Emphasizes Adherence to Hajj Regulations and Announces Penalties
CIA: Iran Likely to Withstand Naval Blockade for Longer Period
Syria: Explosions in Quneitra Following Israeli Strikes on Former Military Sites
Speaker of the House of Representatives: Custodianship over the Holy Sites Is a True Expression of Commitment to the Values of Peace, Love, and Justice
Trump: We Expect a Response from Iran Soon
May 10 2026
11:10 PM
Newsletter
Subscribe
Sign in
My Account
Sign out
#Hikma
Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA
Oct 07,2025
|
Trade & Industry
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
May 11,2025
|
Trade & Industry
Hikma, Celltrion sign monoclonal antibody licensing agreement
Nov 29,2022
|
All
Hikma’s success story: how to revive industry
Oct 15,2022
|
Opinion
HM stresses importance of pharmaceutical sector to economy at Hikma inaugration
Sep 06,2022
|
News
Hikma, Adalvo agree to commercialize allergic Rhinitis
Aug 31,2022
|
All
Hikma, MPP sign licensing agreement for COVID-19 pill
Jan 21,2022
|
All
Hikma to acquire Custopharm for $375 million
Sep 27,2021
|
News
Hikma announces good 2021 start, reiterates full year guidance
May 01,2021
|
All